Cargando…
Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases
The recent derivation of disease-specific induced pluripotent stem cells (iPSCs) from somatic cells of patients with familial and sporadic forms of diseases and the demonstration of their ability to give rise to disease-relevant cell types provide an excellent opportunity to gain further insights in...
Autores principales: | Huang, Hsiang-Po, Chuang, Ching-Yu, Kuo, Hung-Chih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580472/ https://www.ncbi.nlm.nih.gov/pubmed/22925465 http://dx.doi.org/10.1186/scrt125 |
Ejemplares similares
-
Induced pluripotent stem cell models of lysosomal storage disorders
por: Borger, Daniel K., et al.
Publicado: (2017) -
Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2020) -
Lysosomes and Lysosomal Storage Diseases
por: Noebels, Jeffrey L.
Publicado: (1981) -
A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells
por: Christensen, Chloe L., et al.
Publicado: (2017) -
Lysosomal storage diseases
por: Ferreira, Carlos R., et al.
Publicado: (2017)